Literature DB >> 33409970

Sleeve Gastrectomy, One-Anastomosis Gastric Bypass (OAGB), and Single Anastomosis Sleeve Ileal (SASI) Bypass in Treatment of Morbid Obesity: a Retrospective Cohort Study.

Tarek Mahdy1,2, Waleed Gado1, Abdulwahid Alwahidi2, Carl Schou3, Sameh Hany Emile4.   

Abstract

PURPOSE: Bariatric surgery is the most effective treatment for morbid obesity. The present study aimed to assess three bariatric procedures with different mechanisms of actions; sleeve gastrectomy (SG), one-anastomosis gastric bypass (OAGB), and single anastomosis sleeve ileal (SASI) bypass, in terms of efficacy and safety.
METHODS: This was a retrospective cohort study on patients with morbid obesity who underwent SG, OAGB, or SASI bypass. The main outcome measures were weight loss and improvement in comorbidities at 6 and 12 months postoperatively, and complications.
RESULTS: A total of 264 patients (186 female) with mean preoperative body mass index (BMI) of 43.6 ± 9.9 kg/m2were included to the study. Significant weight loss was recorded at 6 and 12 months after the three procedures. At 6 and 12 months postoperatively, body weight and BMI were significantly lower after SASI bypass than after SG and OAGB. The %total weight loss (%TWL) and %excess weight loss (%EWL) were significantly higher after SASI bypass than after SG and OAGB. SASI bypass was associated with a significantly higher rate of improvement in DM than SG and OAGB (97.7% vs 71.4% vs 86.7%; p = 0.04) whereas improvement in other comorbidities was similar. The short-term complication rate was similar between the three procedures, yet SASI bypass was followed by higher long-term complication rate.
CONCLUSION: Based on retrospective review of data, SASI bypass was associated with more reduction in body weight and BMI, higher %TWL and %EWL, better improvement in T2DM, and more long-term nutritional complications than SG and OAGB.

Entities:  

Keywords:  OAGB; Obesity; One-anastomosis gastric bypass; SASI; SG; Sleeve gastrectomy

Mesh:

Year:  2021        PMID: 33409970     DOI: 10.1007/s11695-020-05159-y

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  19 in total

Review 1.  The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives.

Authors:  Lei Chen; Dianna J Magliano; Paul Z Zimmet
Journal:  Nat Rev Endocrinol       Date:  2011-11-08       Impact factor: 43.330

2.  Impact of preoperative body mass index on the final outcome after laparoscopic sleeve gastrectomy for morbid obesity.

Authors:  Hosam Elbanna; Wagih Ghnnam; Ahmed Negm; Tamer Youssef; Sameh Emile; Tito El Metwally; Khaled Elalfy
Journal:  Ulus Cerrahi Derg       Date:  2016-12-01

3.  Gastroesophageal Reflux Disease After Sleeve Gastrectomy: the Need to Predict its Onset and Prevent its Consequences.

Authors:  Sameh Hany Emile
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

4.  Bariatric surgery versus intensive medical therapy in obese patients with diabetes.

Authors:  Philip R Schauer; Sangeeta R Kashyap; Kathy Wolski; Stacy A Brethauer; John P Kirwan; Claire E Pothier; Susan Thomas; Beth Abood; Steven E Nissen; Deepak L Bhatt
Journal:  N Engl J Med       Date:  2012-03-26       Impact factor: 91.245

5.  Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients.

Authors:  Robert Rutledge; Thomas R Walsh
Journal:  Obes Surg       Date:  2005-10       Impact factor: 4.129

6.  Sleeve gastrectomy with transit bipartition: a potent intervention for metabolic syndrome and obesity.

Authors:  Sergio Santoro; Luis Carlos Castro; Manoel Carlos Prieto Velhote; Carlos Eduardo Malzoni; Sidney Klajner; Leandro Perandin Castro; Arnaldo Lacombe; Marco Aurélio Santo
Journal:  Ann Surg       Date:  2012-07       Impact factor: 12.969

Review 7.  Laparoscopic Sleeve Gastrectomy Then and Now: An Updated Systematic Review of the Progress and Short-term Outcomes Over the Last 5 Years.

Authors:  Sameh H Emile; Hossam Elfeki; Khaled Elalfy; Emad Abdallah
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2017-10       Impact factor: 1.719

8.  Preliminary results from digestive adaptation: a new surgical proposal for treating obesity, based on physiology and evolution.

Authors:  Sérgio Santoro; Manoel Carlos Prieto Velhote; Carlos Eduardo Malzoni; Fábio Quirino Milleo; Sidney Klajner; Fábio Guilherme Campos
Journal:  Sao Paulo Med J       Date:  2006-07-06       Impact factor: 1.044

9.  Efficacy of single anastomosis sleeve ileal (SASI) bypass for type-2 diabetic morbid obese patients: Gastric bipartition, a novel metabolic surgery procedure: A retrospective cohort study.

Authors:  T Mahdy; A Al Wahedi; C Schou
Journal:  Int J Surg       Date:  2016-08-19       Impact factor: 6.071

Review 10.  Current status of mini-gastric bypass.

Authors:  Kamal K Mahawar; Parveen Kumar; William Rj Carr; Neil Jennings; Norbert Schroeder; Shlok Balupuri; Peter K Small
Journal:  J Minim Access Surg       Date:  2016 Oct-Dec       Impact factor: 1.407

View more
  4 in total

1.  Exclusions May Be Dismissed if the Ileum Is Early and Potently Stimulated.

Authors:  Sergio Santoro; Caio Gustavo Gaspar Aquino; Filippe Camarotto Mota
Journal:  Obes Surg       Date:  2021-06-29       Impact factor: 4.129

2.  Retrospective Comparison of SADI-S Versus RYGB in Chinese with Diabetes and BMI< 35kg/m2: a Propensity Score Adjustment Analysis.

Authors:  Qing Sang; Liang Wang; Qiqige Wuyun; Xuejing Zheng; Dezhong Wang; Nengwei Zhang; Dexiao Du
Journal:  Obes Surg       Date:  2021-09-30       Impact factor: 4.129

3.  Single anastomosis sleeve ileal bypass (SASI): a single-center initial report.

Authors:  Wiesław Tarnowski; Krzysztof Barski; Paweł Jaworski; Artur Binda; Emilia Kudlicka; Michał Wąsowski; Piotr Jankowski
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2022-03-25       Impact factor: 1.627

4.  Roux-en-Y Gastric Bypass with Long Biliopancreatic Limb Compared to Single Anastomosis Sleeve Ileal (SASI) Bypass in Treatment of Morbid Obesity.

Authors:  Tarek Mahdy; Sameh Hany Emile; Abdulwahid Alwahedi; Waleed Gado; Carl Schou; Amr Madyan
Journal:  Obes Surg       Date:  2021-05-03       Impact factor: 4.129

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.